Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Roivant Sciences Ltd (NASDAQ: ROIV) was $22.5 for the day, up 0.22% from the previous closing price of $22.45. In other words, the price has increased by $0.22 from its previous closing price. On the day, 3.72 million shares were traded. ROIV stock price reached its highest trading level at $22.72 during the session, while it also had its lowest trading level at $22.415.
Ratios:
Our analysis of ROIV’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 33.70 and its Current Ratio is at 33.70. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Citigroup on September 02, 2025, initiated with a Buy rating and assigned the stock a target price of $16.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $17.Wolfe Research initiated its Outperform rating on February 15, 2024, with a $17 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 23 ’25 when RICHARD PULIK bought 260,000 shares for $22.45 per share.
RICHARD PULIK TRUST bought 146,731 shares of ROIV for $3,285,755 on Dec 23 ’25. On Dec 23 ’25, another insider, ERIC VENKER, who serves as the Officer of the company, bought 200,000 shares for $22.45 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ROIV now has a Market Capitalization of 15648561152 and an Enterprise Value of 11804699648. For the stock, the TTM Price-to-Sale (P/S) ratio is 769.73 while its Price-to-Book (P/B) ratio in mrq is 3.56. Its current Enterprise Value per Revenue stands at 580.683 whereas that against EBITDA is -10.65.
Stock Price History:
The Beta on a monthly basis for ROIV is 1.23, which has changed by 0.90677965 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, ROIV has reached a high of $23.47, while it has fallen to a 52-week low of $8.73. The 50-Day Moving Average of the stock is 10.91%, while the 200-Day Moving Average is calculated to be 61.37%.
Shares Statistics:
ROIV traded an average of 8.26M shares per day over the past three months and 11242520 shares per day over the past ten days. A total of 689.70M shares are outstanding, with a floating share count of 437.46M. Insiders hold about 37.10% of the company’s shares, while institutions hold 63.51% stake in the company. Shares short for ROIV as of 1765756800 were 17520355 with a Short Ratio of 2.12, compared to 1763078400 on 23049893. Therefore, it implies a Short% of Shares Outstanding of 17520355 and a Short% of Float of 3.36.
Earnings Estimates
Roivant Sciences Ltd (ROIV) is presently subject to a detailed evaluation by 4.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.25 and low estimates of -$0.51.
Analysts are recommending an EPS of between -$0.86 and -$1.46 for the fiscal current year, implying an average EPS of -$1.09. EPS for the following year is -$1.13, with 4.0 analysts recommending between -$0.59 and -$1.9.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 8 analysts. It ranges from a high estimate of $15M to a low estimate of $1.78M. As of. The current estimate, Roivant Sciences Ltd’s year-ago sales were $9.02MFor the next quarter, 8 analysts are estimating revenue of $6.75M. There is a high estimate of $15M for the next quarter, whereas the lowest estimate is $2M.
A total of 10 analysts have provided revenue estimates for ROIV’s current fiscal year. The highest revenue estimate was $34M, while the lowest revenue estimate was $3.74M, resulting in an average revenue estimate of $15.94M. In the same quarter a year ago, actual revenue was $29.05MBased on 10 analysts’ estimates, the company’s revenue will be $118.13M in the next fiscal year. The high estimate is $466.13M and the low estimate is $6M.
